会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 85. 发明授权
    • Glutamic acid receptor agonist
    • 谷氨酸受体激动剂
    • US5955505A
    • 1999-09-21
    • US894433
    • 1997-08-20
    • Jiro TakeoShinya YamashitaKeiji WadaYoshiyuki Chiba
    • Jiro TakeoShinya YamashitaKeiji WadaYoshiyuki Chiba
    • A61K31/00A61K31/18A61K31/192A61K31/195A61K31/216A61K31/4035A61K31/4406C07C317/28C07C323/49C07C323/56C07C323/62A61K31/44
    • C07C323/62A61K31/00A61K31/18A61K31/192A61K31/195A61K31/216A61K31/4035A61K31/4406C07C317/28C07C323/49C07C323/56
    • A method comprising administering a sulfonamide derivative to a patient requiring activation of glutamate receptors, the sulfonamide derivative represented by the formula ##STR1## wherein A is a napthyl group, a pyridyl group, a phenyl group, a phenyl group substituted by 1 to 5 members selected from the group consisting of a halogen atom, an alkyl group having 1 to 40 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a nitro group, and an acetamido group, or an alkyl group having 1 to 20 carbon atoms; B is an alkylene group having 1 to 3 carbon atoms, a group of --OCH.sub.2 -- or a group of --CH.dbd.CH--; X and Y are the same or different, and are each a hydrogen atom or a fluorine atom; R is a carboxy group, an alkoxycarbonyl group having 2 to 5 carbon atoms, a hydroxymethyl group or a group of ##STR2## wherein R.sub.1 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms; and R.sub.2 is a hydrogen atom, a hydroxyl group, an alkyl group having 1 to 3 carbon atoms, a carboxymethyl group or an alkoxycarbonylmethyl group having 3 to 6 carbon atoms; m is an integer from 0 to 2; and n is an integer from 0 to 3, or an pharmaceutically acceptable salt thereof, as an effective ingredient. The agonist is efficacious in the medical treatment of nerve degenerative disorders.
    • PCT No.PCT / JP96 / 00379 Sec。 371日期1997年8月20日 102(e)日期1997年8月20日PCT提交1996年2月20日PCT公布。 公开号WO96 / 25926 日期:1996年8月29日一种方法,包括向需要谷氨酸受体活化的患者施用磺酰胺衍生物,其中A为萘基,吡啶基,苯基,被1〜 5个选自卤素原子,具有1至40个碳原子的烷基,具有1至4个碳原子的烷氧基,硝基和乙酰氨基,或具有1至20个碳的烷基的基团 原子 B是具有1至3个碳原子的亚烷基,-OCH 2 - 或-CH = CH-的基团; X和Y相同或不同,分别为氢原子或氟原子; R为羧基,碳原子数2〜5的烷氧基羰基,羟甲基或其中R1为氢原子或碳原子数1〜3的烷基的基团。 R2为氢原子,羟基,碳原子数为1〜3的烷基,羧甲基或碳原子数为3〜6的烷氧基羰基甲基。 m为0〜2的整数; n为0〜3的整数,或其药学上可接受的盐作为有效成分。 激动剂在神经退行性疾病的治疗中是有效的。
    • 90. 发明授权
    • .alpha.-acyloxy-.beta.-amino-thiocarboxylic acid esters
    • α-酰氧基-β-氨基 - 硫代羧酸酯
    • US5817859A
    • 1998-10-06
    • US878079
    • 1997-06-18
    • Takayuki SuzukiYutaka HondaKunisuke Izawa
    • Takayuki SuzukiYutaka HondaKunisuke Izawa
    • C07C317/28C07C323/29C07C327/30C07C327/22
    • C07C323/29C07C317/28C07C327/30
    • The present invention provides a simple and inexpensive method for producing a-hydroxy-.beta.-aminocarboxylic acids and their esters. An ester of an N-protected .alpha.-amino acid ester is converted into a .beta.-ketosulfoxide, which is then processed with an acid to give an .alpha.-ketohemimercaptal. Next, this is acylated and then processed with a base to obtain an N-protected .alpha.-acyloxy-.beta.-amino-thioester, which is then saponified to obtain an intended compound. According to the method of the present invention, it is possible to produce .alpha.-hydroxy-.beta.-aminocarboxylic acid derivatives, which are intermediates in producing various HIV protease inhibitors, renin inhibitors and carcinostatics, from a-amino acids. The method comprises reduced reaction steps, the selectivity in the method to give the intended product is high, and the yield of the product obtained is high.
    • 本发明提供了一种简单且廉价的α-羟基-β-氨基羧酸及其酯的制备方法。 将N-保护的α-氨基酸酯的酯转化成β-酮亚砜,然后用酸处理,得到α-酮基二巯基。 接下来,将其进行酰化,然后用碱处理,得到N-保护的α-酰氧基-β-氨基 - 硫代酯,然后皂化,得到目标化合物。 根据本发明的方法,可以生产α-羟基-β-氨基羧酸衍生物,它们是从α-氨基酸生产各种HIV蛋白酶抑制剂,肾素抑制剂和制癌剂的中间体。 该方法包括减少反应步骤,得到所需产物的方法中的选择性高,所得产物的产率高。